Supplement Clinical Trial
Official title:
Alleviating Effects Against High Intraocular Pressure by Oral Intake of Cordyceps Cicadae Mycelia
Verified date | March 2022 |
Source | Chung Shan Medical University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will investigate the effects of lowering intraocular pressure by oral intake of Cordyceps cicadae mycelia, to provide evidence-based data for high intraocular pressure relief.
Status | Completed |
Enrollment | 46 |
Est. completion date | December 31, 2021 |
Est. primary completion date | July 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 75 Years |
Eligibility | Inclusion Criteria: 1. Age between 20 and 75 years old, regardless of gender. 2. Pre-test confirmation of high intraocular pressure. 3. Subjects should understand the trial and agree to join the project. Exclusion Criteria: 1. Age under 20 or over 75 years. 2. Use intraocular pressure lowering drugs other than Taflotan (saflutan). 3. Using beta-blockers or diuretics. 4. Being pregnant. 5. Disabled individuals with specific diseases or malfunction, for example tumours at terminal stage, blindness. 6. Loss of self-consciousness and behavioral capacity. 7. Patients with major diseases. Withdrawal criteria All subjects may withdraw at any time without any reason. The act of withdraw does not affect rights for them to seek medical advice or treatments. |
Country | Name | City | State |
---|---|---|---|
Taiwan | Han-Hsin Chang | Taichung |
Lead Sponsor | Collaborator |
---|---|
Han-Hsin Chang | Grape King Bio Ltd. |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Intraocular pressure | Intraocular pressure of both eyes will be assessed | 0 minutes (before given Cordyceps Cicadae Mycelia) | |
Primary | Intraocular pressure | Intraocular pressure of both eyes will be assessed | 90 minutes after given Cordyceps Cicadae Mycelia | |
Primary | Blood pressure | Both systolic and diastolic blood pressures will be assessed | 0 minutes (before given Cordyceps Cicadae Mycelia) | |
Primary | Blood pressure | Both systolic and diastolic blood pressures will be assessed | 90 minutes after given Cordyceps Cicadae Mycelia |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04065061 -
Erinacine A-enriched Hericium Erinaceus Mycelia for Improvement of Recognition, Vision, and Functional MRI Alterations
|
N/A | |
Completed |
NCT01971723 -
Multi-ingredient Supplement for Strength and Power
|
N/A | |
Completed |
NCT04199234 -
A Study to Compare the Tolerability of Microencapsulated Iron Compared to a Conventional Iron Supplement in the Market
|
N/A | |
Completed |
NCT03769012 -
Ability of Beta-glucan Supplementation to Augment Immune Function
|
N/A | |
Completed |
NCT04063735 -
Alleviating Effects Against Dry Eye by Oral Intake of Cordyceps Cicadae Mycelia
|
N/A |